On 3/26/24, Tandem Diabetes Care Inc (NASDAQ: TNDM) stock enjoyed a major increase of 11.9%, closing at $33.69. Moreover, above average trading volume at 137% of normal accompanied the advance. The stock has risen 8.3% during the last week and has performed in line with the market over the last nine months.
Current PriceTarget Research Rating
TNDM’s future returns on capital are forecasted to be in line with the cost of capital. Accordingly, the company is expected to continue to be Value Creation neutral.
Tandem Diabetes Care has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects complementary signals from PTR’s two proprietary measures of a stock’s attractiveness. Tandem Diabetes Care has a slightly negative Power Rating of 33 and a very low Appreciation Score of 5, and the Lowest Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment